Femasys
FEMY • NASDAQ
Femasys is a medical - instruments & supplies company in the healthcare sector trading on NASDAQ, led by CEO Kathy Lee-Sepsick, with a market cap of $28.7M.
CEOKathy Lee-Sepsick
Next Earnings
Upcoming earnings announcement for Femasys
Date
Thursday, May 7, 2026 (in 3 weeks)
Timing
Before Market Open (8:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.10
Revenue Estimate
$605.5K
Earnings History
Past 12 earnings reports for Femasys
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 31, 2026 | Q4 2025 | -$0.06Est: -$0.08 | +25.0% | $813.4KEst: $1.1M | -23.3% |  10-K |
| Nov 14, 2025 | Q3 2025 | -$0.10Est: -$0.13 | +23.1% | $729.4KEst: $1.4M | -46.0% | 10-Q |
| Aug 8, 2025 | Q2 2025 | -$0.16Est: -$0.18 | +11.1% | $409.3KEst: $1.0M | -59.9% | 10-Q |
| May 8, 2025 | Q1 2025 | -$0.23Est: -$0.15 | -53.3% | $341.3KEst: $1.1M | -69.3% | 10-Q |
| Mar 27, 2025 | Q4 2024 | -$0.23Est: -$0.18 | -27.8% | $581.6KEst: $1.8M | -67.1% | 10-K |
| Nov 12, 2024 | Q3 2024 | -$0.24Est: -$0.20 | -20.0% | $554.9KEst: $652.3K | -14.9% | 10-Q |
| Aug 8, 2024 | Q2 2024 | -$0.21Est: -$0.17 | -23.5% | $221.5KEst: $780.0K | -71.6% | 10-Q |
| May 9, 2024 | Q1 2024 | -$0.17Est: -$0.22 | +22.7% | $271.1KEst: $300.0K | -9.6% | 10-Q |
| Mar 28, 2024 | Q4 2023 | -$0.19Est: -$0.21 | +9.5% | $213.1KEst: $240.0K | -11.2% | 10-K/A |
| Nov 14, 2023 | Q3 2023 | -$0.26Est: -$0.22 | -18.2% | $244.4KEst: $280.0K | -12.7% | — |
| Aug 10, 2023 | Q2 2023 | -$0.22Est: -$0.19 | -15.8% | $320.5KEst: $270.0K | +18.7% | — |
| May 11, 2023 | Q1 2023 | -$0.25Est: -$0.26 | +3.8% | $294.0KEst: $340.0K | -13.5% | — |